NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Purevdorj Olkhanud, M.D., Ph.D., M.P.H.

Program Director

NCI Division of Cancer Treatment and Diagnosis (DCTD) - Cancer Therapy Evaluation Program (CTEP)
Clinical Grants and Contracts Branch (CGCB)

240-276-3535 | purevdorj.olkhanud@nih.gov

Dr. Olkhanud joined the Clinical Grants and Contracts Branch as a Program Director in 2023. Before joining CTEP, Dr. Olkhanud conducted research at the NCI Center for Cancer Research (CCR) and at Johns Hopkins University. His areas of expertise include cancer vaccines, tumor immunology, and cancer drug development.